Skip to content
A current study suggests that scientists from Hiroshima University in Japan may have found a way to remove allergens that eggs usually contain. According […]
Egg allergens may be removed thanks to gene editing Read More »
Exciting new therapies promise to transform medicine. But ensuring patients can access these complex treatments may require innovative payment models, says a study published
Transformative therapies need new payment models, study finds Read More »
Drug makers have been racing at a breakneck pace to develop respiratory syncytial virus (RSV) vaccines this year. On May 3, the U.S. Food
FDA approves first RSV vaccine Read More »
The Senate Health, Education, Labor, and Pension (HELP) Committee on May 2 discussed Senate Bill 1339, “The Pharmacy Benefit Manager Reform Act,” and three
Vote on Pharmacy Benefit Manager Reform Act delayed until May 11 Read More »
On April 26, the U.S. Food and Drug Administration (FDA) approved the first investigational microbiome therapeutic for treating recurrent Clostridioides difficile infection in adults.
FDA approves first microbiome therapeutic for C. diff infection in adults Read More »
Despite progress from some U.S. trading partners in developing global intellectual property protections that enable innovation, much improvement is needed, according to the Special
USTR calls out countries needing better IP protections in annual report Read More »
Ordinary market mechanisms are inadequate against the emerging public health threat of antimicrobial resistance (AMR), lawmakers and experts agreed at the April 28 hearing
Hearing on public health threat from AMR puts spotlight on PASTEUR Act Read More »
Every April, the FDA observes National Minority Health Month “to raise awareness of the importance of improving the health of racial and ethnic minority
National Minority Health Month: in conversation with Dr. Reed Tuckson and Reggie Ware Read More »
On April 27, a group of bipartisan U.S. Senators and U.S. Representatives reintroduced the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act. The
PASTEUR Act reintroduced in House, Senate Read More »
Pharmacy benefit managers (or PBMs) are in the news again as federal regulators and politicians work to shed light on the questionable and purposefully
The Senate Finance Committee trains its sights on PBMs Read More »
